| A molecular atlas of cell types and zonation in the brain vasculature M Vanlandewijck, L He, MA Mäe, J Andrae, K Ando, F Del Gaudio, ... Nature 554 (7693), 475-480, 2018 | 1507 | 2018 |
| Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types L He, M Vanlandewijck, MA Mäe, J Andrae, K Ando, F Del Gaudio, ... Scientific data 5 (1), 1-11, 2018 | 362 | 2018 |
| VEGF‐B‐induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart R Kivelä, M Bry, MR Robciuc, M Räsänen, M Taavitsainen, JMU Silvola, ... EMBO molecular medicine 6 (3), 307-321, 2014 | 179 | 2014 |
| Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2–implications for microvascular inflammation and hypercoagulopathy in COVID-19 L He, MA Mäe, L Muhl, Y Sun, R Pietilä, K Nahar, EV Liébanas, ... BioRxiv, 2020 | 134 | 2020 |
| VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection M Räsänen, J Degerman, TA Nissinen, I Miinalainen, R Kerkelä, ... Proceedings of the National Academy of Sciences 113 (46), 13144-13149, 2016 | 123 | 2016 |
| Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes TA Nissinen, J Degerman, M Räsänen, AR Poikonen, S Koskinen, ... Scientific reports 6 (1), 1-16, 2016 | 79 | 2016 |
| VEGF-B promotes endocardium-derived coronary vessel development and cardiac regeneration M Räsänen, I Sultan, J Paech, KA Hemanthakumar, W Yu, L He, J Tang, ... Circulation 143 (1), 65-77, 2021 | 74 | 2021 |
| Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle JJ Hulmi, TA Nissinen, M Räsänen, J Degerman, JH Lautaoja, ... Journal of cachexia, sarcopenia and muscle 9 (2), 417-432, 2018 | 63 | 2018 |
| Frequency, reasons, and impact of premature ticagrelor discontinuation in patients undergoing coronary revascularization in routine clinical practice: results from the Bern … T Zanchin, F Temperli, A Karagiannis, C Zanchin, M Räsänen, ... Circulation: Cardiovascular Interventions 11 (5), e006132, 2018 | 54 | 2018 |
| The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research L Muhl, L He, Y Sun, MA Mäe, R Pietilä, J Liu, G Genové, L Zhang, Y Xie, ... Stem cell reports 17 (5), 1089-1104, 2022 | 48 | 2022 |
| Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling T Holopainen, M Räsänen, A Anisimov, T Tuomainen, W Zheng, ... Proceedings of the National Academy of Sciences 112 (42), 13063-13068, 2015 | 36 | 2015 |
| Systemic blockade of ACVR2B ligands protects myocardium from acute ischemia-reperfusion injury J Magga, L Vainio, T Kilpiö, JJ Hulmi, S Taponen, R Lin, M Räsänen, ... Molecular therapy 27 (3), 600-610, 2019 | 33 | 2019 |
| Susceptibility to cardiac arrhythmias and sympathetic nerve growth in VEGF-B overexpressing myocardium J Lähteenvuo, OP Hätinen, A Kuivanen, J Huusko, J Paananen, ... Molecular therapy 28 (7), 1731-1740, 2020 | 24 | 2020 |
| Author Correction: A molecular atlas of cell types and zonation in the brain vasculature M Vanlandewijck, L He, MA Mäe, J Andrae, K Ando, F Del Gaudio, ... Nature 560 (7716), E3-E3, 2018 | 19 | 2018 |
| Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart R Shang, N Lal, CS Lee, Y Zhai, K Puri, O Seira, RC Boushel, I Sultan, ... American Journal of Physiology-Endocrinology and Metabolism 321 (6), E753-E765, 2021 | 10 | 2021 |
| CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel M Ramste, M Ritvos, S Häyrynen, JI Kiiski, M Niemi, J Sinisalo Clinical and translational science 16 (10), 2010-2020, 2023 | 3 | 2023 |
| Genome-Wide Genetic Associations Prioritize Evaluation of Causal Mechanisms of Atherosclerotic Disease Risk T Quertermous, DY Li, CS Weldy, M Ramste, D Sharma, JP Monteiro, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (2), 323-327, 2024 | 1 | 2024 |
| The α2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud’s syndrome A Tervi, M Ramste, E Abner, P Cheng, JM Lane, M Maher, V Lammi, ... Medrxiv, 2023.10. 04.23296526, 2023 | 1 | 2023 |
| Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy I Sultan, M Ramste, P Peletier, KA Hemanthakumar, D Ramanujam, ... Circulation Research 134 (11), 1465-1482, 2024 | | 2024 |
| Divergent trends in the incidence and mortality of coronary events, especially in women. Evidence from Finland in 1996-2021. A Kallstrom, I Holopainen, O Kambur, M Perola, V Salomaa, ... medRxiv, 2023.12. 01.23299126, 2023 | | 2023 |
